Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
Phase 2 Completed
55 enrolled 10 charts
AREST
Phase NA Completed
392 enrolled
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Phase NA Completed
2 enrolled
Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer
Phase 2 Completed
316 enrolled 31 charts
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract
Phase 3 Completed
311 enrolled
AACER
Phase 2 Completed
53 enrolled
ECHO-07
Phase 2 Completed
42 enrolled 24 charts
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
Completed
130 enrolled
ROOT
Completed
167 enrolled
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Phase 1 Completed
48 enrolled
Radiotherapy of Tongue Cancer Using an Intraoral Stent
Phase 1 Completed
13 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
Phase 2 Completed
90 enrolled 7 charts
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome Measure
Completed
1,745 enrolled
PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 1/2 Completed
12 enrolled 11 charts
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Completed
893 enrolled
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase 3 Completed
91 enrolled 16 charts
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Completed
37 enrolled 6 charts
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
Phase 1/2 Completed
37 enrolled 9 charts
Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Phase 2 Completed
30 enrolled 16 charts
ADCC
Phase 1 Completed
24 enrolled
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Phase 1/2 Completed
70 enrolled
Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors
Phase NA Completed
42 enrolled
Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
Phase NA Completed
68 enrolled
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase 2/3 Completed
196 enrolled 13 charts
Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy
Phase NA Completed
30 enrolled
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Phase 1/2 Completed
25 enrolled 14 charts
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase 2 Completed
34 enrolled 16 charts
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer
Completed
3 enrolled
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
3 enrolled
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Phase 2 Completed
24 enrolled
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Phase 1/2 Completed
37 enrolled 6 charts
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed
44 enrolled 9 charts
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Phase 3 Completed
155 enrolled 12 charts
Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871
Completed
69 enrolled
Zinc Supplements in Lowering Cadmium Levels in Smokers
Phase 2 Completed
61 enrolled
MAESTRO HN
Phase 2 Completed
86 enrolled 11 charts
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
Phase 2 Completed
55 enrolled 8 charts
Vaccine Therapy in Treating Patients With Head and Neck Cancer
Phase 1 Completed
17 enrolled
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Phase 4 Completed
642 enrolled 8 charts
CAPRA
Phase 1/2 Completed
49 enrolled
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Phase 1 Completed
43 enrolled
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
Phase 2 Completed
6 enrolled
Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 2 Completed
30 enrolled
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Phase 1 Completed
13 enrolled
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Phase 2 Completed
325 enrolled 15 charts
Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
15 enrolled 8 charts
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 1 Completed
30 enrolled
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
71 enrolled 8 charts